BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17595177)

  • 1. Evidence and implications of haemoglobin cycling in anaemia management.
    Fishbane S; Berns JS
    Nephrol Dial Transplant; 2007 Aug; 22(8):2129-32. PubMed ID: 17595177
    [No Abstract]   [Full Text] [Related]  

  • 2. New developments in anemia management in chronic kidney disease.
    Amerling R; Besarab A; Roy C
    Nephrol News Issues; 2008 Mar; 22(3):suppl 1-8. PubMed ID: 18372676
    [No Abstract]   [Full Text] [Related]  

  • 3. The CARI guidelines. Biochemical and haematological targets. Haemoglobin.
    McMahon L;
    Nephrology (Carlton); 2008 Jul; 13 Suppl 2():S44-56. PubMed ID: 18713123
    [No Abstract]   [Full Text] [Related]  

  • 4. KHA-CARI guideline: biochemical and haematological targets: haemoglobin concentrations in patients using erythropoietin-stimulating agents.
    McMahon LP; MacGinley R;
    Nephrology (Carlton); 2012 Jan; 17(1):17-9. PubMed ID: 22044720
    [No Abstract]   [Full Text] [Related]  

  • 5. Triumph and tragedy: anemia management in chronic kidney disease.
    Novak JE; Szczech LA
    Curr Opin Nephrol Hypertens; 2008 Nov; 17(6):580-8. PubMed ID: 18941350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing renal anaemia management--benefits of early referral and treatment.
    Stevens P
    Nephrol Dial Transplant; 2005 Sep; 20 Suppl 8():viii22-26. PubMed ID: 16079327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Erythropoietin in hematology and oncology. I. Chronic anemia in malignant disease and the pharmacology of erythropoietin].
    Adam Z; Krejcí M; Vorlícek J
    Vnitr Lek; 1996 Apr; 42(4):285-9. PubMed ID: 8693717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaemia management in chronic kidney disease patients: an overview of current clinical practice.
    Valderrábano F
    Nephrol Dial Transplant; 2002; 17 Suppl 1():13-8. PubMed ID: 11812907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Present and future strategies in the treatment of renal anaemia.
    Macdougall IC
    Nephrol Dial Transplant; 2001; 16 Suppl 5():50-5. PubMed ID: 11509685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latest US KDOQI Anaemia Guidelines update--what are the implications for Europe?
    Macdougall IC; Eckardt KU; Locatelli F
    Nephrol Dial Transplant; 2007 Oct; 22(10):2738-42. PubMed ID: 17906324
    [No Abstract]   [Full Text] [Related]  

  • 11. Anemia and anemia correction: surrogate markers or causes of morbidity in chronic kidney disease?
    Vaziri ND
    Nat Clin Pract Nephrol; 2008 Aug; 4(8):436-45. PubMed ID: 18542121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [There are no differences between non-diabetics and diabetics with respect to the effect of anaemia correction in chronic kidney disease].
    García López FJ
    Nefrologia; 2010; 30(2):258-9. PubMed ID: 20393624
    [No Abstract]   [Full Text] [Related]  

  • 13. [Should we modify hemoglobin targets in CKD patients? FDA and EMEA statements].
    Martín de Francisco AL; Aljama P; Arias M; Górriz JL; Martínez Castelao A; Portolés J
    Nefrologia; 2007; 27(4):399-404. PubMed ID: 17944575
    [No Abstract]   [Full Text] [Related]  

  • 14. Erythropoietin stimulating agents and epoetin alfa revisited: what's really relevant?
    Walker RG
    Clin J Am Soc Nephrol; 2008 Jul; 3(4):935-7. PubMed ID: 18579671
    [No Abstract]   [Full Text] [Related]  

  • 15. [What are the aims and targets of renal anemia therapy?].
    Eckardt KU
    Dtsch Med Wochenschr; 2007 Sep; 132(36):1837-41. PubMed ID: 17726657
    [No Abstract]   [Full Text] [Related]  

  • 16. [Update on the management of anemia. Nephrology World Congress 2009].
    Verhelst D
    Nephrol Ther; 2010 Jun; 6(3 Suppl):1-9. PubMed ID: 20538247
    [No Abstract]   [Full Text] [Related]  

  • 17. Erythropoietin and intravenous iron therapy in postpartum anaemia.
    Wågström E; Akesson A; Van Rooijen M; Larson B; Bremme K
    Acta Obstet Gynecol Scand; 2007; 86(8):957-62. PubMed ID: 17653881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Factors regulating erythropoiesis and their change in certain internal diseases].
    Iaroshevskiĭ AIa
    Ter Arkh; 1967 Feb; 39(2):21-7. PubMed ID: 5611686
    [No Abstract]   [Full Text] [Related]  

  • 19. From anemia trials to clinical practice: understanding the risks and benefits when setting goals for therapy.
    Coyne DW
    Semin Dial; 2008; 21(3):212-6. PubMed ID: 18363603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Erythropoietin].
    Pavlović-Kentera V
    Srp Arh Celok Lek; 1989; 117(9-10):643-8. PubMed ID: 18709763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.